SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013717
Filing Date
2019-11-07
Accepted
2019-11-07 17:16:35
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a20190930-10q.htm   iXBRL 10-Q 1631714
2 EXHIBIT 10.1 bold-20190930xex101.htm EX-10.1 170255
3 EXHIBIT 10.2 bold-20190930xex102.htm EX-10.2 265197
4 EXHIBIT 10.3 bold-20190930xex103.htm EX-10.3 260680
5 EXHIBIT 31.1 bold-20190930xex311.htm EX-31.1 12199
6 EXHIBIT 31.2 bold-20190930xex312.htm EX-31.2 12367
7 EXHIBIT 32.1 bold-20190930xex321.htm EX-32.1 5844
8 EXHIBIT 32.2 bold-20190930xex322.htm EX-32.2 5782
  Complete submission text file 0001628280-19-013717.txt   6969201

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bold-20190930.xsd EX-101.SCH 33346
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bold-20190930_cal.xml EX-101.CAL 67375
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bold-20190930_def.xml EX-101.DEF 146482
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bold-20190930_lab.xml EX-101.LAB 511460
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bold-20190930_pre.xml EX-101.PRE 296021
17 EXTRACTED XBRL INSTANCE DOCUMENT a20190930-10q_htm.xml XML 1040108
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37833 | Film No.: 191201327
SIC: 2836 Biological Products, (No Diagnostic Substances)